OMIM# |
NAME |
GENE |
102700 |
SEVERE COMBINED IMMUNODEFICIENCY, AR, T CELL-NEGATIVE, |
ADA |
102770 |
MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO |
AMPD1 |
105830 |
ANGELMAN SYNDROME AS |
MECP2 |
107400 |
PROTEASE INHIBITOR 1; PI |
SERPINA1 |
124000 |
MITOCHONDRIAL COMPLEX III DEFICIENCY |
BCS1L |
124000 |
MITOCHONDRIAL COMPLEX III DEFICIENCY |
UQCRB |
124000 |
MITOCHONDRIAL COMPLEX III DEFICIENCY |
UQCRQ |
133540 |
COCKAYNE SYNDROME, B; CSB |
ERCC6 |
141800 |
HEMOGLOBIN--ALPHA LOCUS 1; HBA1 |
HBA1 |
141900 |
HEMOGLOBIN--BETA LOCUS; HBB |
HBB |
145900 |
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS. CMT3, CMT4F |
EGR2 |
145900 |
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS. CMT3, CMT4F |
MPZ |
145900 |
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS. CMT3, CMT4F |
PMP22 |
145900 |
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS. CMT3, CMT4F |
PRX |
188055 |
THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE |
F5 |
190685 |
DOWN SYNDROME |
GATA1 |
200100 |
ABETALIPOPROTEINEMIA; ABL |
MTTP |
200990 |
ACROCALLOSAL SYNDROME; ACLS |
GLI3 |
201000 |
CARPENTER SYNDROME |
RAB23 |
201450 |
ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF |
ACADM |
201460 |
ACYL-CoA DEHYDROGENASE, LONG-CHAIN, DEFICIENCY OF |
ACADL |
201470 |
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF |
ACADS |
201475 |
ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF |
ACADVL |
201710 |
LIPOID CONGENITAL ADRENAL HYPERPLASIA |
CYP11A1 |
201710 |
LIPOID CONGENITAL ADRENAL HYPERPLASIA |
STAR |
201910 |
CONGENITAL ADRENAL HYPERPLASIA, 21-HYDROXYLASE DEFICIENCY |
CYP21A2 |
202400 |
AFIBRINOGENEMIA, CONGENITAL |
FGA |
202400 |
AFIBRINOGENEMIA, CONGENITAL |
FGB |
202400 |
AFIBRINOGENEMIA, CONGENITAL |
FGG |
203500 |
ALKAPTONURIA |
HGD |
203700 |
ALPERS DIFFUSE CEREBRAL DEGENERATION WITH HEPATIC CIRRHOSIS |
POLG |
203780 |
ALPORT SYNDROME, AR |
COL4A3 |
203780 |
ALPORT SYNDROME, AR |
COL4A4 |
203800 |
ALSTROM SYNDROME; ALMS |
ALMS1 |
204200 |
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3 |
CLN3 |
204500 |
CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2 |
TPP1 |
205100 |
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2 |
ALS2 |
206700 |
ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL DEFICIENCY |
PAX6 |
207410 |
ANTLEY-BIXLER SYNDROME; ABS |
FGFR2 |
207900 |
ARGININOSUCCINIC ACIDURIA |
ASL |
208000 |
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY; GACI |
ENPP1 |
208085 |
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS |
VPS33B |
208150 |
FETAL AKINESIA DEATION SEQUENCE; FADS |
RAPSN |
208400 |
ASPARTYLGLUCOSAMINURIA |
AGA |
208540 |
RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD |
NPHP3 |
208900 |
ATAXIA-TELANGIECTASIA; AT |
ATM |
208920 |
EARLY-ONSET ATAXIA WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA |
APTX |
210210 |
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY |
MCCC2 |
210600 |
SECKEL SYNDROME 1 |
ATR |
210900 |
BLOOM SYNDROME; BLM |
BLM |
211600 |
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1 |
ATP8B1 |
211750 |
C SYNDROME |
CD96 |
212065 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ia; CDG1A |
PMM2 |
212066 |
CONGENITAL DISORDER OF GLYCOSYLATION, IIa; CDG2A |
MGAT2 |
212720 |
MARTSOLF SYNDROME |
RAB3GAP2 |
213700 |
CEREBROTENDINOUS XANTHOMATOSIS |
CYP27A1 |
214150 |
CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1 |
ERCC6 |
214450 |
GRISCELLI SYNDROME, 1; GS1 |
MYO5A |
214500 |
CHEDIAK-HIGASHI SYNDROME; CHS |
LYST |
214950 |
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 |
AMACR |
215045 |
CHONDRODYSPLASIA, BLOMSTRAND ; BOCD |
PTH1R |
215100 |
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, 1; RCDP1 |
PEX7 |
215140 |
HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA |
LBR |
215150 |
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED |
COL11A2 |
215150 |
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED |
COL2A1 |
215600 |
CIRRHOSIS, FAMILIAL |
KRT18 |
215600 |
CIRRHOSIS, FAMILIAL |
KRT8 |
215700 |
CITRULLINEMIA, CLASSIC |
ASS1 |
216400 |
COCKAYNE SYNDROME, A; CSA |
ERCC8 |
216550 |
COHEN SYNDROME; COH1 |
VPS13B |
217090 |
PLASMINOGEN DEFICIENCY, I |
PLG |
217400 |
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS |
SLC4A11 |
218000 |
AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN |
SLC12A6 |
219000 |
FRASER SYNDROME |
FRAS1 |
219000 |
FRASER SYNDROME |
FREM2 |
219100 |
CUTIS LAXA, AR, I |
EFEMP2 |
219100 |
CUTIS LAXA, AR, I |
FBLN5 |
219200 |
CUTIS LAXA, AR, II |
ATP6V0A2 |
219700 |
CYSTIC FIBROSIS; CF |
CFTR |
219750 |
CYSTINOSIS, ADULT NONNEPHROPATHIC |
CTNS |
219800 |
CYSTINOSIS, NEPHROPATHIC; CTNS |
CTNS |
219900 |
CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC |
CTNS |
220111 |
LEIGH SYNDROME, FRENCH-CANADIAN ; LSFC |
LRPPRC |
220290 |
DEAFNESS, AR 1A |
GJB2 |
220400 |
JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1 |
KCNQ1 |
222448 |
DONNAI-BARROW SYNDROME |
LRP2 |
222600 |
DIASTROPHIC DYSPLASIA |
SLC26A2 |
223900 |
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, III; HSAN3 |
IKBKAP |
224050 |
CEREBELLAR HYPOPLASIA AND MENTAL RETARDATION |
VLDLR |
224410 |
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER ; DDSH |
HSPG2 |
225320 |
EHLERS-DANLOS SYNDROME, AR, CARDIAC VALVULAR |
COL1A2 |
225410 |
EHLERS-DANLOS SYNDROME, VII, AR |
ADAMTS2 |
225750 |
AICARDI-GOUTIERES SYNDROME 1; AGS1 |
TREX1 |
225753 |
PONTOCEREBELLAR HYPOPLASIA 4; PCH4 |
TSEN54 |
226600 |
EPIDERMOLYSIS BULLOSA DYSTROPHICA, AR; RDEB |
COL7A1 |
226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ |
COL17A1 |
226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ |
ITGB4 |
226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ |
LAMA3 |
226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ |
LAMB3 |
226650 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ |
LAMC2 |
226670 |
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY |
PLEC1 |
226700 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ |
LAMA3 |
226700 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ |
LAMB3 |
226700 |
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ |
LAMC2 |
226730 |
EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA |
ITGA6 |
226730 |
EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA |
ITGB4 |
226980 |
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS |
EIF2AK3 |
228600 |
FIBROMATOSIS, JUVENILE HYALINE |
ANTXR2 |
228930 |
FIBULAR APLASIA OR HYPOPLASIA |
WNT7A |
229200 |
BRITTLE CORNEA SYNDROME; BCS |
ZNF469 |
229600 |
FRUCTOSE INTOLERANCE, HEREDITARY |
ALDOB |
230000 |
FUCOSIDOSIS |
FUCA1 |
230400 |
GALACTOSEMIA |
GALT |
230500 |
GM1-GANGLIOSIDOSIS, I |
GLB1 |
230600 |
GM1-GANGLIOSIDOSIS, II |
GLB1 |
230800 |
GAUCHER DISEASE, I |
GBA |
230900 |
GAUCHER DISEASE, II |
GBA |
231000 |
GAUCHER DISEASE, III |
GBA |
231050 |
GELEOPHYSIC DYSPLASIA |
ADAMTSL2 |
231530 |
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY |
HADH |
231550 |
ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAA |
AAAS |
231670 |
GLUTARIC ACIDEMIA I |
GCDH |
231680 |
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD |
ETFA |
231680 |
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD |
ETFB |
231680 |
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD |
ETFDH |
232200 |
GLYCOGEN STORAGE DISEASE I |
G6PC3 |
232220 |
GLYCOGEN STORAGE DISEASE Ib |
SLC37A4 |
232240 |
GLYCOGEN STORAGE DISEASE Ic |
SLC37A4 |
232300 |
GLYCOGEN STORAGE DISEASE II |
GAA |
232400 |
GLYCOGEN STORAGE DISEASE III |
AGL |
232500 |
GLYCOGEN STORAGE DISEASE IV |
GBE1 |
235200 |
HEMOCHROMATOSIS; HFE |
HFE |
235200 |
HEMOCHROMATOSIS; HFE |
HFE2 |
235550 |
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI |
SP110 |
236200 |
HOMOCYSTINURIA |
CBS |
236250 |
HOMOCYSTINURIA DUE TO DEFICIENCY OF METHYLENETETRAHYDROFOLATE |
MTHFR |
236490 |
HYALINOSIS, INFANTILE SYSTEMIC |
ANTXR2 |
236670 |
WALKER-WARBURG SYNDROME; WWS |
POMT1 |
236670 |
WALKER-WARBURG SYNDROME; WWS |
POMT2 |
236680 |
HYDROLETHALUS SYNDROME 1 |
HYLS1 |
237300 |
CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA |
CPS1 |
237310 |
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY |
NAGS |
238970 |
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME |
SLC25A15 |
239000 |
PAGET DISEASE, JUVENILE |
TNFRSF11B |
240300 |
AUTOIMMUNE POLYENDOCRINE SYNDROME, I; APS1 |
AIRE |
241200 |
BARTTER SYNDROME, ANTENATAL, 2 |
KCNJ1 |
241410 |
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD |
TBCE |
241510 |
HYPOPHOSPHATASIA, CHILDHOOD |
ALPL |
241520 |
HYPOPHOSPHATEMIC RICKETS, AR |
DMP1 |
241550 |
HYPOPLASTIC LEFT HEART SYNDROME |
GJA1 |
242300 |
ICHTHYOSIS, LAMELLAR, 1; LI1 |
TGM1 |
242500 |
ICHTHYOSIS CONGENITA, HARLEQUIN FETUS |
ABCA12 |
242860 |
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME |
DNMT3B |
243500 |
ISOVALERIC ACIDEMIA; IVA |
IVD |
243800 |
JOHANSON-BLIZZARD SYNDROME; JBS |
UBR1 |
244460 |
KENNY-CAFFEY SYNDROME, 1; KCS |
TBCE |
245200 |
KRABBE DISEASE |
GALC |
245349 |
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY |
PDHX |
245400 |
LACTIC ACIDOSIS, FATAL INFANTILE |
SUCLG1 |
245660 |
LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS |
LAMA3 |
246200 |
DONOHUE SYNDROME |
INSR |
246450 |
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY |
HMGCL |
248190 |
HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT |
CLDN19 |
248500 |
MANNOSIDOSIS, ALPHA B, LYSOSOMAL |
MAN2B1 |
248600 |
MAPLE SYRUP URINE DISEASE Ia |
BCKDHA |
248600 |
MAPLE SYRUP URINE DISEASE, CLASSIC, IB |
BCKDHB |
248600 |
MAPLE SYRUP URINE DISEASE III |
DLD |
248800 |
Marinesco-Sjogren Syndrome |
SIL1 |
249000 |
MECKEL SYNDROME, 1; MKS1 |
MKS1 |
249100 |
FAMILIAL MEDITERRANEAN FEVER; FMF |
MEFV |
249900 |
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY |
PSAP |
250100 |
METACHROMATIC LEUKODYSTROPHY |
ARSA |
250250 |
CARTILAGE-HAIR HYPOPLASIA; CHH |
RMRP |
250620 |
BETA-HYDROXYISOBUTYRYL CoA DEACYLASE, DEFICIENCY OF |
HIBCH |
250950 |
3-METHYLGLUTACONIC ACIDURIA, I |
AUH |
251000 |
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY |
MUT |
251110 |
METHYLMALONIC ACIDURIA, cblB |
MMAB |
251260 |
NIJMEGEN BREAKAGE SYNDROME |
NBN |
251880 |
MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL |
C10ORF2 |
251880 |
MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL |
DGUOK |
251880 |
MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL |
MPV17 |
252150 |
MOLYBDENUM COFACTOR DEFICIENCY |
MOCS1 |
252150 |
MOLYBDENUM COFACTOR DEFICIENCY |
MOCS2 |
252500 |
MUCOLIPIDOSIS II ALPHA/BETA |
GNPTAB |
252600 |
MUCOLIPIDOSIS III ALPHA/BETA |
GNPTAB |
252650 |
MUCOLIPIDOSIS IV |
MCOLN1 |
252900 |
MUCOPOLYSACCHARIDOSIS IIIA |
SGSH |
252930 |
MUCOPOLYSACCHARIDOSIS IIIC |
HGSNAT |
253200 |
MUCOPOLYSACCHARIDOSIS VI |
ARSB |
253220 |
MUCOPOLYSACCHARIDOSIS VII |
GUSB |
253230 |
MUCOPOLYSACCHARIDOSIS VIII |
GNS |
253250 |
MULIBREY NANISM |
TRIM37 |
253260 |
BIOTINIDASE DEFICIENCY |
BTD |
253280 |
MUSCLE-EYE-BRAIN DISEASE; MEB |
FKRP |
253280 |
MUSCLE-EYE-BRAIN DISEASE; MEB |
POMGNT1 |
253290 |
MULTIPLE PTERYGIUM SYNDROME, LETHAL |
CHRNA1 |
253290 |
MULTIPLE PTERYGIUM SYNDROME, LETHAL |
CHRND |
253290 |
MULTIPLE PTERYGIUM SYNDROME, LETHAL |
CHRNG |
253300 |
SPINAL MUSCULAR ATROPHY, I; SMA1 |
SMN1 |
253310 |
LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1 |
GLE1 |
253400 |
SPINAL MUSCULAR ATROPHY, III; SMA3 |
SMN1 |
253550 |
SPINAL MUSCULAR ATROPHY, II; SMA2 |
SMN1 |
253800 |
FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; FCMD |
FKTN |
254780 |
MYOCLONIC EPILEPSY OF LAFORA |
EPM2A |
254780 |
MYOCLONIC EPILEPSY OF LAFORA |
NHLRC1 |
254800 |
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG |
CSTB |
255110 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET |
CPT2 |
255120 |
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY |
CPT1A |
255960 |
MYXOMA, INTRACARDIAC |
PRKAR1A |
256030 |
NEMALINE MYOPATHY 2; NEM2 |
NEB |
256050 |
ATELOSTEOGENESIS, II; AOII |
SLC26A2 |
256100 |
NEPHRONOPHTHISIS 1; NPHP1 |
NPHP1 |
256300 |
NEPHROSIS 1, CONGENITAL, FINNISH ; NPHS1 |
NPHS1 |
256370 |
NEPHROTIC SYNDROME, EARLY-ONSET, WITH DIFFUSE MESANGIAL SCLEROSIS |
WT1 |
256550 |
NEURAMINIDASE DEFICIENCY |
NEU1 |
256600 |
NEUROAXONAL DYSTROPHY, INFANTILE; INAD1 |
PLA2G6 |
256710 |
ELEJALDE DISEASE |
MYO5A |
256730 |
CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1 |
PPT1 |
256731 |
CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5 |
CLN5 |
256800 |
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA |
NTRK1 |
256810 |
NAVAJO NEUROHEPATOPATHY; NN |
MPV17 |
257200 |
NIEMANN-PICK DISEASE, A |
SMPD1 |
257220 |
NIEMANN-PICK DISEASE, C1; NPC1 |
NPC1 |
257320 |
LISSENCEPHALY 2; LIS2 |
RELN |
257980 |
ODONTOONYCHODERMAL DYSPLASIA; OODD |
WNT10A |
258501 |
3-METHYLGLUTACONIC ACIDURIA, III |
OPA3 |
259700 |
OSTEOPETROSIS, AR 1; OPTB1 |
TCIRG1 |
259720 |
OSTEOPETROSIS, AR 5; OPTB5 |
OSTM1 |
259730 |
OSTEOPETROSIS, AR 3; OPTB3 |
CA2 |
259770 |
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG |
LRP5 |
259775 |
RAINE SYNDROME; RNS |
FAM20C |
259900 |
HYPEROXALURIA, PRIMARY, I |
AGXT |
260000 |
HYPEROXALURIA, PRIMARY, II |
GRHPR |
260400 |
SHWACHMAN-DIAMOND SYNDROME; SDS |
SBDS |
261515 |
D-BIFUNCTIONAL PROTEIN DEFICIENCY |
HSD17B4 |
261600 |
PHENYLKETONURIA; PKU |
PAH |
261740 |
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL |
PRKAG2 |
262300 |
ACHROMATOPSIA 3; ACHM3 |
CNGB3 |
262600 |
PITUITARY DWARFISM III |
HESX1 |
262600 |
PITUITARY DWARFISM III |
LHX3 |
262600 |
PITUITARY DWARFISM III |
POU1F1 |
262600 |
PITUITARY DWARFISM III |
PROP1 |
263200 |
POLYCYSTIC KIDNEY DISEASE, AR; ARPKD |
PKHD1 |
263700 |
PORPHYRIA, CONGENITAL ERYTHROPOIETIC |
UROS |
264350 |
PSEUDOHYPOALDOSTERONISM, I, AR; PHA1 |
SCNN1A |
264350 |
PSEUDOHYPOALDOSTERONISM, I, AR; PHA1 |
SCNN1B |
264350 |
PSEUDOHYPOALDOSTERONISM, I, AR; PHA1 |
SCNN1G |
264470 |
PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY |
ACOX1 |
264700 |
VITAMIN D-DEPENDENT RICKETS, I |
CYP27B1 |
265000 |
MULTIPLE PTERYGIUM SYNDROME, ESCOBAR |
CHRNG |
265100 |
PULMONARY ALVEOLAR MICROLITHIASIS |
SLC34A2 |
265120 |
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1 |
SFTPB |
265380 |
NEWBORN PULMONARY HYPERTENSION, FAMILIAL PERSISTENT |
CPS1 |
265450 |
PULMONARY VENOOCCLUSIVE DISEASE; PVOD |
BMPR2 |
265800 |
PYCNODYSOSTOSIS |
CTSK |
266130 |
GLUTATHIONE SYNTHETASE DEFICIENCY |
GSS |
266150 |
PYRUVATE CARBOXYLASE DEFICIENCY |
PC |
266200 |
PYRUVATE KINASE DEFICIENCY OF RED CELLS |
PKLR |
266265 |
CONGENITAL DISORDER OF GLYCOSYLATION, IIc; CDG2C |
SLC35C1 |
266900 |
SENIOR-LOKEN SYNDROME 1; SLSN1 |
NPHP1 |
267430 |
RENAL TUBULAR DYSGENESIS; RTD |
ACE |
267430 |
RENAL TUBULAR DYSGENESIS; RTD |
AGT |
267430 |
RENAL TUBULAR DYSGENESIS; RTD |
AGTR1 |
267430 |
RENAL TUBULAR DYSGENESIS; RTD |
REN |
267450 |
RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS |
SFTPA1 |
267450 |
RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS |
SFTPB |
267450 |
RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS |
SFTPC |
268300 |
ROBERTS SYNDROME; RBS |
ESCO2 |
268800 |
SANDHOFF DISEASE |
HEXB |
269250 |
SCHNECKENBECKEN DYSPLASIA |
SLC35D1 |
269920 |
INFANTILE SIALIC ACID STORAGE DISORDER |
SLC17A5 |
270200 |
SJOGREN-LARSSON SYNDROME; SLS |
ALDH3A2 |
270400 |
SMITH-LEMLI-OPITZ SYNDROME; SLOS |
DHCR7 |
270450 |
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO |
IGF1 |
270550 |
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY ; SACS |
SACS |
271245 |
INFANTILE-ONSET SPINOCEREBELLAR ATAXIA; IOSCA |
C10ORF2 |
271900 |
CANAVAN DISEASE |
ASPA |
271930 |
STRIATONIGRAL DEGENERATION, INFANTILE; SNDI |
NUP62 |
271980 |
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY |
ALDH5A1 |
272300 |
SULFOCYSTEINURIA |
SUOX |
272800 |
TAY-SACHS DISEASE; TSD |
HEXA |
273395 |
TETRA-AMELIA, AR |
WNT3 |
274150 |
THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP |
ADAMTS13 |
274270 |
DIHYDROPYRIMIDINE DEHYDROGENASE; DPYD |
DPYD |
274600 |
PENDRED SYNDROME; PDS |
SLC26A4 |
275100 |
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4 |
TSHB |
275210 |
TIGHT SKIN CONTRACTURE SYNDROME, LETHAL |
LMNA |
275210 |
TIGHT SKIN CONTRACTURE SYNDROME, LETHAL |
ZMPSTE24 |
276700 |
TYROSINEMIA, I |
FAH |
276820 |
ULNA AND FIBULA, ABSENCE OF |
WNT7A |
276900 |
USHER SYNDROME, I |
MYO7A |
276901 |
USHER SYNDROME, IIA; USH2A |
USH2A |
276902 |
USHER SYNDROME, III; USH3 |
CLRN1 |
276904 |
USHER SYNDROME, IC; USH1C |
USH1C |
277300 |
SPONDYLOCOSTAL DYSOSTOSIS, AR 1; SCDO1 |
DLL3 |
277400 |
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC |
MMACHC |
277440 |
VITAMIN D-DEPENDENT RICKETS, II |
VDR |
277460 |
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED |
TTPA |
277470 |
PONTOCEREBELLAR HYPOPLASIA 2A; PCH2A |
TSEN54 |
277580 |
WAARDENBURG-SHAH SYNDROME |
EDN3 |
277580 |
WAARDENBURG-SHAH SYNDROME |
EDNRB |
277580 |
WAARDENBURG-SHAH SYNDROME |
SOX10 |
277900 |
WILSON DISEASE |
ATP7B |
278700 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA |
XPA |
278730 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD |
ERCC2 |
278740 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E |
DDB2 |
278760 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF |
ERCC4 |
278780 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG |
ERCC5 |
278800 |
DE SANCTIS-CACCHIONE SYNDROME |
ERCC6 |
278800 |
DE SANCTIS-CACCHIONE SYNDROME |
XPA |
300004 |
CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA |
ARX |
300018 |
DOSAGE-SENSITIVE SEX REVERSAL; DSS |
NR0B1 |
300048 |
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, XLR |
FLNA |
300067 |
LISSENCEPHALY, XLR, 1; LISX1 |
DCX |
300069 |
CARDIOMYOPATHY, DILATED, 3A; CMD3A |
TAZ |
300100 |
ADRENOLEUKODYSTROPHY; ALD |
ABCD1 |
300209 |
SIMPSON-GOLABI-BEHMEL SYNDROME, 2 |
OFD1 |
300215 |
LISSENCEPHALY, XLR, 2 LISX2 |
ARX |
300220 |
MENTAL RETARDATION, XLR, SYNDROMIC 10; MRXS10 |
HSD17B10 |
300240 |
HOYERAAL-HREIDARSSON SYNDROME; HHS |
DKC1 |
300243 |
MENTAL RETARDATION, XLR, SYNDROMIC, CHRISTIANSON |
SLC9A6 |
300291 |
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY |
IKBKG |
300301 |
OSTEOPETROSIS, LYMPHEDEMA, ECTODERMAL DYSPLASIA, ANHIDROSIS, IMMUNODEFICIENCY |
IKBKG |
300322 |
LESCH-NYHAN SYNDROME; LNS |
HPRT1 |
300352 |
CREATINE DEFICIENCY SYNDROME, XLR |
SLC6A8 |
300400 |
SEVERE COMBINED IMMUNODEFICIENCY, XLR; SCIDX1 |
IL2RG |
300472 |
AGENESIS OF CORPUS CALLOSUM WITH MENTAL RETARDATION, OCULAR COLOBOMA |
IGBP1 |
300523 |
ALLAN-HERNDON-DUDLEY SYNDROME AHDS |
SLC16A2 |
300672 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2 |
CDKL5 |
300673 |
ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS |
MECP2 |
300755 |
AGAMMAGLOBULINEMIA, XLR XLA |
BTK |
301000 |
WISKOTT-ALDRICH SYNDROME; WAS |
WAS |
301040 |
α-THALASSEMIA/MENTAL RETARDATION SYNDROME,NONDELETION , XLR ATRX |
ATRX |
301500 |
FABRY DISEASE |
GLA |
301830 |
SPINAL MUSCULAR ATROPHY, XLR 2; SMAX2 |
UBA1 |
301835 |
ARTS SYNDROME; ARTS |
PRPS1 |
302045 |
CARDIOMYOPATHY, DILATED, 3B; CMD3B |
DMD |
302060 |
BARTH SYNDROME; BTHS |
TAZ |
302950 |
CHONDRODYSPLASIA PUNCTATA 1, XLR RECESSIVE; CDPX1 |
ARSE |
303100 |
CHOROIDEREMIA; CHM |
CHM |
303350 |
MASA SYNDROME |
L1CAM |
304100 |
CORPUS CALLOSUM, PARTIAL AGENESIS OF, XLR |
L1CAM |
304790 |
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, XLR |
FOXP3 |
305100 |
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, XLR; XHED |
EDA |
305900 |
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD |
G6PD |
306955 |
HETEROTAXY, VISCERAL, 1, XLR; HTX1 |
ZIC3 |
307000 |
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS |
L1CAM |
308230 |
IMMUNODEFICIENCY WITH HYPER-IgM, 1; HIGM1 |
CD40LG |
308240 |
LYMPHOPROLIFERATIVE SYNDROME, XLR, 1; XLP1 |
SH2D1A |
308350 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1 |
ARX |
308370 |
INFERTILE MALE SYNDROME |
AR |
308930 |
LEIGH SYNDROME, XLR |
PDHA1 |
309000 |
LOWE OCULOCEREBRORENAL SYNDROME; OCRL |
OCRL |
309400 |
MENKES DISEASE |
ATP7A |
309500 |
RENPENNING SYNDROME 1; RENS1 |
PQBP1 |
309520 |
LUJAN-FRYNS SYNDROME |
MED12 |
310200 |
MUSCULAR DYSTROPHY, DUCHENNE ; DMD |
DMD |
310400 |
MYOTUBULAR MYOPATHY 1; MTM1 |
MTM1 |
310600 |
NORRIE DISEASE; ND |
NDP |
311150 |
OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA |
TIMM8A |
311250 |
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO |
OTC |
312060 |
PROPERDIN DEFICIENCY, XLR |
CFP |
312080 |
PELIZAEUS-MERZBACHER DISEASE; PMD |
PLP1 |
312700 |
RETINOSCHISIS 1, XLR, JUVENILE; RS1 |
RS1 |
312750 |
RETT SYNDROME; RTT |
MECP2 |
312863 |
COMBINED IMMUNODEFICIENCY, XLR; CIDX |
IL2RG |
312920 |
SPASTIC PARAPLEGIA 2, XLR; SPG2 |
PLP1 |
314390 |
VACTERL ASSOCIATION WITH HYDROCEPHALUS, XLR |
FANCB |
600060 |
DEAFNESS, NEUROSENSORY, AR 2; DFNB2 |
MYO7A |
600118 |
WARBURG MICRO SYNDROME; WARBM |
RAB3GAP1 |
600121 |
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, 3; RCDP3 |
AGPS |
600143 |
CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8 |
CLN8 |
600501 |
ABCD SYNDROME |
EDNRB |
600649 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE |
CPT2 |
600721 |
D-2-HYDROXYGLUTARIC ACIDURIA |
D2HGDH |
600737 |
INCLUSION BODY MYOPATHY 2, AR; IBM2 |
GNE |
600802 |
SEVERE COMBINED IMMUNODEFICIENCY, AR, T CELL- B CELL+, NK CELL- |
JAK3 |
600972 |
ACHONDROGENESIS, IB; ACG1B |
SLC26A2 |
601067 |
USHER SYNDROME, ID; USH1D |
CDH23 |
601186 |
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9 |
STRA6 |
601378 |
CRISPONI SYNDROME |
CRLF1 |
601451 |
NEVO SYNDROME |
PLOD1 |
601457 |
SEVERE COMBINED IMMUNODEFICIENCY, AR, T CELL-NEGATIVE, |
RAG1 |
601457 |
SEVERE COMBINED IMMUNODEFICIENCY, AR, T CELL-NEGATIVE, |
RAG2 |
601559 |
STUVE-WIEDEMANN SYNDROME |
LIFR |
601675 |
TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP |
ERCC2 |
601675 |
TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP |
ERCC3 |
601675 |
TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP |
GTF2H5 |
601678 |
BARTTER SYNDROME, ANTENATAL, 1 |
SLC12A1 |
601705 |
T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY |
FOXN1 |
601706 |
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME |
SOX10 |
601780 |
CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6 |
CLN6 |
601847 |
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2; PFIC2 |
ABCB11 |
602083 |
USHER SYNDROME, IF; USH1F |
PCDH15 |
602088 |
NEPHRONOPHTHISIS 2; NPHP2 |
INVS |
602390 |
HEMOCHROMATOSIS, JUVENILE; JH |
HAMP |
602390 |
HEMOCHROMATOSIS, JUVENILE; JH |
HFE2 |
602398 |
DESMOSTEROLOSIS |
DHCR24 |
602473 |
ENCEPHALOPATHY, ETHYLMALONIC |
ETHE1 |
602579 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ib; CDG1B |
MPI |
602771 |
RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1 |
SEPN1 |
603147 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ic; CDG1C |
ALG6 |
603358 |
GRACILE SYNDROME |
BCS1L |
603554 |
OMENN SYNDROME |
DCLRE1C |
603554 |
OMENN SYNDROME |
RAG1 |
603554 |
OMENN SYNDROME |
RAG2 |
603585 |
CONGENITAL DISORDER OF GLYCOSYLATION, IIf; CDG2F |
SLC35A1 |
603903 |
SICKLE CELL ANEMIA |
HBB |
604004 |
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; MLC |
MLC1 |
604250 |
HEMOCHROMATOSIS, 3 |
TFR2 |
604320 |
SPINAL MUSCULAR ATROPHY, DISTAL, AR, 1; DSMA1 |
IGHMBP2 |
604369 |
SIALURIA, FINNISH |
SLC17A5 |
604377 |
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE |
SCO2 |
604498 |
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT |
MPL |
605039 |
C-LIKE SYNDROME |
CD96 |
605253 |
NEUROPATHY, HYPOMYELINATING/CHARCOT-MARIE-TOOTH DISEASE, 4E |
EGR2 |
605253 |
NEUROPATHY, HYPOMYELINATING/CHARCOT-MARIE-TOOTH DISEASE, 4E |
MPZ |
605355 |
NEMALINE MYOPATHY 5; NEM5 |
TNNT1 |
605407 |
SEGAWA SYNDROME, AR |
TH |
605472 |
USHER SYNDROME, IIC; USH2C |
GPR98 |
605899 |
GLYCINE ENCEPHALOPATHY; GCE |
AMT |
605899 |
GLYCINE ENCEPHALOPATHY; GCE |
GCSH |
605899 |
GLYCINE ENCEPHALOPATHY; GCE |
GLDC |
606056 |
CONGENITAL DISORDER OF GLYCOSYLATION, IIb; CDG2B |
MOGS |
606353 |
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ |
ALS2 |
606369 |
EPILEPTIC ENCEPHALOPATHY, LENNOX-GASTAUT |
MAPK10 |
606407 |
HYPOTONIA-CYSTINURIA SYNDROME |
PREPL |
606407 |
HYPOTONIA-CYSTINURIA SYNDROME |
SLC3A1 |
606612 |
MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C |
FKRP |
606812 |
FUMARASE DEFICIENCY |
FH |
606943 |
USHER SYNDROME, IG; USH1G |
USH1G |
606966 |
NEPHRONOPHTHISIS 4; NPHP4 |
NPHP4 |
607014 |
HURLER SYNDROME |
IDUA |
607091 |
CONGENITAL DISORDER OF GLYCOSYLATION, IId; CDG2D |
B4GALT1 |
607095 |
ANAUXETIC DYSPLASIA |
RMRP |
607330 |
LATHOSTEROLOSIS |
SC5DL |
607426 |
COENZYME Q10 DEFICIENCY |
APTX |
607426 |
COENZYME Q10 DEFICIENCY |
CABC1 |
607426 |
COENZYME Q10 DEFICIENCY |
COQ2 |
607426 |
COENZYME Q10 DEFICIENCY |
PDSS1 |
607426 |
COENZYME Q10 DEFICIENCY |
PDSS2 |
607598 |
ICOS DEFICIENCY; LCCS2 |
ERBB3 |
607616 |
NIEMANN-PICK DISEASE, B |
SMPD1 |
607624 |
GRISCELLI SYNDROME, 2; GS2 |
RAB27A |
607625 |
NIEMANN-PICK DISEASE, C2 |
NPC2 |
607626 |
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS |
CLDN1 |
607655 |
SKIN FRAGILITY-WOOLLY HAIR SYNDROME |
DSP |
607855 |
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A |
LAMA2 |
608013 |
GAUCHER DISEASE, PERINATAL LETHAL |
GBA |
608093 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ij; CDG1J |
DPAGT1 |
608099 |
MUSCULAR DYSTROPHY, LIMB-GIRDLE, 2D; LGMD2D |
SGCA |
608456 |
COLORECTAL ADENOMATOUS POLYPOSIS, AR |
MUTYH |
608540 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ik; CDG1K |
ALG1 |
608612 |
MANDIBULOACRAL DYSPLASIA WITH B LIPODYSTROPHY; MADB |
ZMPSTE24 |
608629 |
JOUBERT SYNDROME 3; JBTS3 |
AHI1 |
608643 |
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY |
DDC |
608688 |
AICAR TRANSYLASE/IMP CYCLOHYDROLASE, DEFICIENCY OF |
ATIC |
608782 |
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY |
PDP1 |
608799 |
CONGENITAL DISORDER OF GLYCOSYLATION, Ie; CDG1E |
DPM1 |
608800 |
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT |
TSPYL1 |
608804 |
LEUKODYSTROPHY, HYPOMYELINATING, 2 |
GJC2 |
608836 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL |
CPT2 |
608840 |
MUSCULAR DYSTROPHY, CONGENITAL, 1D |
LARGE |
609015 |
TRIFUNCTIONAL PROTEIN DEFICIENCY |
HADHA |
609015 |
TRIFUNCTIONAL PROTEIN DEFICIENCY |
HADHB |
609016 |
LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY |
HADHA |
609049 |
PIERSON SYNDROME |
LAMB2 |
609056 |
AMISH INFANTILE EPILEPSY SYNDROME |
ST3GAL5 |
609060 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1 |
GFM1 |
609241 |
SCHINDLER DISEASE, I |
NAGA |
609254 |
SENIOR-LOKEN SYNDROME 5; SLSN5 |
IQCB1 |
609304 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3 |
SLC25A22 |
609311 |
CHARCOT-MARIE-TOOTH DISEASE, 4H; CMT4H |
FGD4 |
609528 |
CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, PALMOPLANTAR KERATODERMA |
SNAP29 |
609560 |
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC |
TK2 |
609583 |
JOUBERT SYNDROME 4; JBTS4 |
NPHP1 |
609638 |
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC |
DSP |
610003 |
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY |
CLN8 |
610006 |
2-METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY |
ACADSB |
610090 |
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY |
PNPO |
610127 |
CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10 |
CTSD |
610188 |
JOUBERT SYNDROME 5; JBTS5 |
CEP290 |
610198 |
3-METHYLGLUTACONIC ACIDURIA, V |
DNAJC19 |
610370 |
DIARRHEA 4, MALABSORPTIVE, CONGENITAL |
NEUROG3 |
610377 |
MEVALONIC ACIDURIA |
MVK |
610498 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2 |
MRPS16 |
610505 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3 |
TSFM |
610532 |
LEUKODYSTROPHY, HYPOMYELINATING, 5 |
FAM126A |
610651 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB |
ERCC3 |
610688 |
JOUBERT SYNDROME 6; JBTS6 |
TMEM67 |
610725 |
NEPHROTIC SYNDROME, 3; NPHS3 |
PLCE1 |
610768 |
CONGENITAL DISORDER OF GLYCOSYLATION, Im; CDG1M |
DOLK |
610854 |
OSTEOGENESIS IMPERFECTA, IIB |
CRTAP |
610915 |
OSTEOGENESIS IMPERFECTA, VIII |
LEPRE1 |
610951 |
CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7 |
MFSD8 |
610992 |
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY |
PSAT1 |
611067 |
SPINAL MUSCULAR ATROPHY, DISTAL, AR, 4; DSMA4 |
PLEKHG5 |
611126 |
ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF |
ACAD9 |
611561 |
MECKEL SYNDROME, 5; MKS5 |
RPGRIP1L |
611705 |
MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY |
TTN |
611719 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5 |
MRPS22 |
611721 |
COMBINED SAPOSIN DEFICIENCY |
PSAP |
611722 |
KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY |
PSAP |
611726 |
EPILEPSY, PROGRESSIVE MYOCLONIC 3; EPM3 |
KCTD7 |
612164 |
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4 |
STXBP1 |
612304 |
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL |
PROC |
612416 |
FACTOR XI DEFICIENCY |
F11 |